DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vinorelbine (Vinorelbine) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vinorelbine where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2012-08-08

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-30

Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-30



Possible Vinorelbine side effects in female

Reported by a physician from Japan on 2012-07-31

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Subdural Haematoma, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-13
    End date: 2012-07-19

Afinitor
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2012-07-24

Afinitor
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-13
    End date: 2012-07-13

Vinorelbine
    Start date: 2012-07-24

Comparator Trastuzumab
    Indication: Breast Cancer
    Start date: 2012-03-13
    End date: 2012-07-19

Zoledronic Acid
    Indication: Metastases To Bone
    Start date: 2011-05-01

Comparator Trastuzumab
    Start date: 2012-07-24

Other drugs received by patient: Loxoprofen; Lansoprazole; Rebamipide; Lyrica; Fentanyl-100; Magmitt



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2012-07-25

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-28

Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-29



Possible Vinorelbine side effects in female

Reported by a physician from Japan on 2012-07-25

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Subdural Haematoma, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-13
    End date: 2012-07-13

Zoledronic Acid
    Dosage: unk
    Indication: Metastases To Bone
    Start date: 2012-03-13

Comparator Trastuzumab
    Dosage: unk
    Start date: 2012-03-13

Vinorelbine
    Dosage: unk
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-13

Other drugs received by patient: Loxoprofen; Lansoprazole; Lyrica; Rebamipide; Magmitt; Fentanyl-100



Possible Vinorelbine side effects in female

Reported by a physician from Japan on 2012-07-19

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Subdural Haematoma, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zoledronic Acid
    Dosage: unk
    Indication: Metastases To Bone
    Start date: 2012-03-13

Vinorelbine
    Dosage: unk
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-13

Afinitor
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-13

Comparator Trastuzumab
    Dosage: unk
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-13

Other drugs received by patient: Magmitt; Loxoprofen; Rebamipide; Lansoprazole; Lyrica; Fentanyl-100



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2012-07-09

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-28

Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-29



Possible Vinorelbine side effects in

Reported by a physician from United States on 2012-07-06

Patient:

Reactions: Respiratory Failure, Anaemia, Neutropenia, Thrombocytopenia, Infection

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: administered on day 1 and day 8 of every 21 day cycle
    Indication: Diffuse Large B-Cell Lymphoma

Vinorelbine
    Dosage: administered on day 1 and day 8 of every 21 day cycle
    Indication: Diffuse Large B-Cell Lymphoma

Colony Stimulating Factor
    Dosage: on day 9 of each cycle
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: administered on day 1 and day 8 of every 21 day cycle
    Indication: Diffuse Large B-Cell Lymphoma

Gemcitabine
    Dosage: administered on day 1 and day 8 of every 21 day cycle
    Indication: Diffuse Large B-Cell Lymphoma



Possible Vinorelbine side effects in 63 year old male

Reported by a consumer/non-health professional from Germany on 2012-06-28

Patient: 63 year old male

Reactions: Anaemia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cetuximab
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-06

Cisplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-06

Vinorelbine
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-06



Possible Vinorelbine side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27

Patient:

Reactions: Respiratory Failure, Anaemia, Neutropenia, Thrombocytopenia, Infection

Drug(s) suspected as cause:
Vinorelbine
    Dosage: administered on day 1 and day 8 of every 21 day cycle
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: administered on day 1 and day 8 of every 21 day cycle
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: administered on day 1 and day 8 of every 21 day cycle
    Indication: Diffuse Large B-Cell Lymphoma

Gemcitabine
    Dosage: administered on day 1 and day 8 of every 21 day cycle
    Indication: Diffuse Large B-Cell Lymphoma

Colony Stimulating Factor
    Dosage: on day 9 of each cycle
    Indication: Diffuse Large B-Cell Lymphoma



Possible Vinorelbine side effects in

Reported by a physician from United States on 2012-06-22

Patient:

Reactions: Thrombosis, Device Related Infection, Headache, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hyperglycaemia, Anaemia, Hypotension, Dehydration, Neutropenia, Bone Pain, Pain, Hypokalaemia, Disease Progression, Death, Postoperative Wound Infection, Fatigue, Neutropenic Infection, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Alanine Aminotransferase Increased, Lymphopenia, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Diarrhoea, Arthralgia, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Docetaxel
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer Metastatic

Vinorelbine
    Dosage: 27.5 mg/m2, per chemo regim
    Indication: Breast Cancer Metastatic

Filgrastim
    Dosage: 5 mug/kg, per chemo regim
    Indication: Breast Cancer Metastatic

Trastuzumab
    Dosage: 2 mg/kg, qwk

Trastuzumab
    Dosage: 4 mg/kg, one time dose
    Indication: Breast Cancer Metastatic



Possible Vinorelbine side effects in 54 year old male

Reported by a consumer/non-health professional from Germany on 2012-05-25

Patient: 54 year old male

Reactions: Diarrhoea, Anaemia, Dehydration

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-09-01

Cetuximab
    Dosage: 250mg/m2, 1 in 1 week
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-09-01
    End date: 2005-09-09

Cetuximab

Vinorelbine
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-09-01



Possible Vinorelbine side effects in 65 year old male

Reported by a consumer/non-health professional from Ireland on 2012-05-23

Patient: 65 year old male

Reactions: Diarrhoea, Anaemia, Dehydration, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-20

Vinorelbine
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-20

Cetuximab
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-20



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2012-03-20

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-29

Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-28



Possible Vinorelbine side effects in female

Reported by a physician from Czech Republic on 2012-02-22

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Vomiting, Diarrhoea, Anaemia, Chest Pain, Pyrexia, Decreased Appetite

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Comparator Trastuzumab
    Dosage: 126 mg, qw
    Start date: 2012-02-01

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-17
    End date: 2012-01-23

Comparator Trastuzumab
    Dosage: 126 mg, qw
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-17
    End date: 2012-01-24

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-17
    End date: 2012-01-23

Blinded Placebo
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-17
    End date: 2012-01-23

Vinorelbine
    Dosage: 41 mg, qw
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-17
    End date: 2012-01-18

Other drugs received by patient: Indap; Neurontin; Zolpidem; Omeprazole; Atenolol



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2012-02-03

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-28

Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-28



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2012-01-27

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-30

Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-30

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017